default author photo

Guru Sonpavde

Harvard University - Lank Center for Genitourinary Oncology

Boston, Massachusetts

United States

SCHOLARLY PAPERS

2

DOWNLOADS

102

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Integrated Clinico-Genomic Analysis of Genetic Ancestry in 1,614 Patients With Cancer Treated With Immune Checkpoint Inhibitors

Number of pages: 57 Posted: 11 Feb 2022
Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Mount Sinai Health System - Division of Hematology and Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Urologic Surgery, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Medical Oncology, Harvard University - Melanoma Center, Harvard University - Department of Pathology, Harvard University - Department of Data Science, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Genetics and Harvard University - Division of Population Sciences
Downloads 54 (1,020,567)

Abstract:

Loading...

Genetic ancestry, cancer, Immunotherapy, immune checkpoint inhibitors

2.

Ethnicity-Specific Variation in the Germline Landscape of Renal Cell Carcinoma

Number of pages: 18 Posted: 15 Oct 2020
Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard Medical School - Division of Pulmonary and Critical Care Medicine and Genetics, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Invitae Corporation, InVitae Corporation, Invitae Corporation, InVitae Corporation, InVitae Corporation, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Division of Population Sciences and Harvard University - Lank Center for Genitourinary Oncology
Downloads 48 (1,086,013)
Citation 1

Abstract:

Loading...

Renal cell carcinoma, kidney cancer, germline variants, DNA damage repair, clinical genetics